To identify genetic vulnerabilities of colon cancer, investigators performed targeted CRISPR dropout screens comprising 657 Drugbank targets and 317 epigenetic regulators on two patient-derived colon cancer stem cells-enriched spheroids.
[Oncogene]
7992332
{7992332:CCCCCCCC}
apa
50
1
167579
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
